Back to search
FDAFDA · Food and drugs·Recall number D-109-2013

Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

Published January 9, 2013 · Recall initiated: September 26, 2012

Summary

FDA records drug Class I recall D-109-2013, published January 9, 2013 and initiated September 26, 2012. Recalling firm: New England Compounding Center; Status: Terminated; Reported quantity: 9062 vials; Lot: All lot codes. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
New England Compounding Center
Distributor
Nationwide
Lot
All lot codes
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA recalled?

Yes. FDA published recall D-109-2013 on January 9, 2013. Reported hazard: Non-Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit